본문 바로가기
KERD
논문KCI 등재

항생제 사용관리 프로그램의 국내 실행을 위한 핵심요소 -종합병원대상-

Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals

김신우|윤영경|정수진|김용찬|이혁민|김봉영|신지연|김형숙|황인선|박춘선|대한감염학회|대한의료관련감염관리학회|문치숙|은병욱|박경화|김홍빈|이미숙|대한소아감염학회|정혜숙|권키태|대한항균요법학회|한국병원약사회
대한내과학회 (The Korean Association Of Internal Medicine)|2023.02|대한내과학회지 (The Korean Journal of Medicine)|제98권 제1호|pp. 11-39|DOI https://doi.org/10.3904/kjm.2023.98.1.11

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

리더십LeadershipAccreditation항생제 내성Antimicrobial drug resistanceFinancial support다학제재정적 지원Multidisciplinary communications의료기관 인증
주제분류내과학

초록

Currently, antimicrobial resistance (AMR) is a major threat to global public health. To overcome this crisis, antimicrobial stewardship programs (ASPs) have been proposed. An ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, as well as the duration and routes of administration. In South Korea, efforts are underway to overcome AMR through a national policy supporting ASPs. This study developed the core elements of an ASP for domestic medical facilities. Two Delphi surveys were conducted to select the core elements through expert consensus. The core elements for ASP implementation included leadership commitment, an operating system, action, tracking, reporting, and education. To ensure that these core elements are present in medical facilities, multiple departments must collaborate to support ASP operations. The establishment of a reimbursement system and workforce for ASPs are prerequisites for ASP implementation. The active implementation of core ASP elements in medical facilities requires the provision of financial support for the ASPs, cultivation of a healthcare workforce to perform ASPs, application of the core elements to healthcare accreditation, and provision of incentives to medical facilities via quality evaluation criteria.

Abstract

Currently, antimicrobial resistance (AMR) is a major threat to global public health. To overcome this crisis, antimicrobial stewardship programs (ASPs) have been proposed. An ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, as well as the duration and routes of administration. In South Korea, efforts are underway to overcome AMR through a national policy supporting ASPs. This study developed the core elements of an ASP for domestic medical facilities. Two Delphi surveys were conducted to select the core elements through expert consensus. The core elements for ASP implementation included leadership commitment, an operating system, action, tracking, reporting, and education. To ensure that these core elements are present in medical facilities, multiple departments must collaborate to support ASP operations. The establishment of a reimbursement system and workforce for ASPs are prerequisites for ASP implementation. The active implementation of core ASP elements in medical facilities requires the provision of financial support for the ASPs, cultivation of a healthcare workforce to perform ASPs, application of the core elements to healthcare accreditation, and provision of incentives to medical facilities via quality evaluation criteria.

참고문헌 (134)

  1. Fridkin S, "Vital signs : improving antibiotic use among hospitalized patients", MMWR Morb Mortal Wkly Rep, 63, pp.194~200 (2014)
  2. "Tackling Drug-Resistant Infections Globally:Final Report and Recommendations" (2016)[URL]
  3. "World Antimicrobial Awareness Week: Campaign Guidance 2021" (2021)[URL]
  4. Park SY, "Appropriateness of antibiotic prescriptions during hospitalization and ambulatory care : a multicentre prevalence survey in Korea", J Glob Antimicrob Resist, 29, pp.253~258 (2022)
  5. Choi SM, "Antimicrobial awareness week", Public Health Wkly Rep, 14, pp.3318~3319 (2021)
  6. Hwang Soyoon, "Core Elements for Successful Implementation of Antimicrobial Stewardship Programs", Infection and Chemotherapy, 53(3), pp.421~435 (2021), 대한감염학회[DOI]
  7. Barlam TF, "Implementing an antibiotic stewardship program : guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America", Clin Infect Dis, 62, pp.e51~e77 (2016)
  8. 권기태, "항생제 사용관리 프로그램의 실행", 대한의사협회지, 65(8), pp.498~504 (2022), 대한의사협회[DOI]
  9. "Global action plan on antimicrobial resistance" (2016)[URL]
  10. Ryu S, "The new Korean action plan for containment of antimicrobial resistance", J Glob Antimicrob Resist, 8, pp.70~73 (2017)
  11. "National Action Plan on Antimicrobial Resisatnce (2021-2025)" (2021)[URL]
  12. Baur D, "Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection : a systematic review and meta-analysis", Lancet Infect Dis, 17, pp.990~1001 (2017)
  13. Karanika S, "Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs", Antimicrob Agents Chemother, 60, pp.4840~4852 (2016)
  14. Cunha CB, "The pharmacoeconomic aspects of antibiotic stewardship programs", Med Clin North Am, 102, pp.937~946 (2018)
  15. Yoon Young Kyung, "Guidelines on Implementing Antimicrobial Stewardship Programs in Korea", Infection and Chemotherapy, 53(3), pp.617~659 (2021), 대한감염학회[DOI]
  16. Ostrowsky B, "Infectious diseases physicians : leading the way in antimicrobial stewardship", Clin Infect Dis, 66, pp.995~1003 (2018)
  17. Pollack LA, "Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention", Clin Infect Dis, 59(Suppl 3), pp.S97~S100 (2014)
  18. Nhan D, "Structure of antimicrobial stewardship programs in leading US hospitals : findings of a nationwide survey", Open Forum Infect Dis, 6, pp.ofz104~ (2019)
  19. Hurst AL, "Handshake stewardship : a highly effective rounding-based antimicrobial optimization service", Pediatr Infect Dis J, 35, pp.1104~1110 (2016)
  20. "Antimicrobial Stewardship in Australian Health Care" (2022)[URL]
  21. "Antimicrobial Stewardship: Final Reprot to the Public Health Network Council" (2016)[URL]
  22. Langford BJ, "Assessing the impact of antibiotic stewardship program elements on antibiotic use across acute-care hospitals : an observational study", Infect Control Hosp Epidemiol, 39, pp.941~946 (2018)
  23. Dellit TH, "Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship", Clin Infect Dis, 44, pp.159~177 (2007)
  24. Le Coz P, "Human resources needed to perform antimicrobial stewardship teams' activities in French hospitals", Med Mal Infect, 46, pp.200~206 (2016)
  25. Doernberg SB, "Essential resources and strategies for antibiotic stewardship programs in the acute care setting", Clin Infect Dis, 67, pp.1168~1174 (2018)
  26. de With K, "Strategies to enhance rational use of antibiotics in hospital : a guideline by the German Society for Infectious Diseases", Infection, 44, pp.395~439 (2016)
  27. Ten Oever J, "Human resources required for antimicrobial stewardship teams : a Dutch consensus report", Clin Microbiol Infect, 24, pp.1273~1279 (2018)
  28. Maeda M, "Essential human resources for antimicrobial stewardship teams in Japan : estimates from a nationwide survey conducted by the Japanese Society of Chemotherapy", J Infect Chemother, 25, pp.653~656 (2019)
  29. Maeda M, "The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy", J Infect Chemother, 25, pp.83~88 (2019)
  30. Park SY, "Human resources required for antimicrobial stewardship activities for hospitalized patients in Korea", Infect Control Hosp Epidemiol, 41, pp.1429~1435 (2020)
  31. Ji W, "Antimicrobial stewardship programs in Northwest China : a cross-sectional survey of perceptions, involvement, and perceived barriers among hospital pharmacists", Front Pharmacol, 12, pp.616503~ (2021)
  32. Heil EL, "The essential role of pharmacists in antimicrobial stewardship", Infect Control Hosp Epidemiol, 37, pp.753~754 (2016)
  33. Waters CD, "Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support", Am J Health Syst Pharm, 72, pp.466~468 (2015)
  34. Fukuda T, "Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429beds--before-after comparative two-year trial in Japan", J Pharm Policy Pract, 7, pp.10~ (2014)
  35. Apisarnthanarak A, "Design and analysis of a pharmacist-enhanced antimicrobial stewardship program in Thailand", Am J Infect Control, 43, pp.956~959 (2015)
  36. Mahmood RK, "Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes : a meta-analysis of evidence", Eur J Hosp Pharm, 29, pp.2~7 (2022)
  37. Apisarnthanarak A, "Antimicrobial stewardship for acute-care hospitals : an Asian perspective", Infect Control Hosp Epidemiol, 39, pp.1237~1245 (2018)
  38. Hyeri Seok, "Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis", Infection and Chemotherapy, 52(1), pp.19~30 (2020), 대한감염학회[DOI]
  39. 김혜인, "항생제 스튜어드십 프로그램에 대한 설문조사", 대한내과학회지, 87(2), pp.173~181 (2014), 대한내과학회[DOI]
  40. Mehta JM, "Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship", Infect Control Hosp Epidemiol, 35, pp.1092~1099 (2014)
  41. 송영주, "Impact of an Antimicrobial Stewardship Program on Unnecessary Double Anaerobic Coverage Prescription", Infection and Chemotherapy, 47(2), pp.111~116 (2015), 대한감염학회[DOI]
  42. De Waele JJ, "Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care : no simple answers to simple questions-a viewpoint of experts", Intensive Care Med, 46, pp.236~244 (2020)
  43. Briceland LL, "Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach", Arch Intern Med, 148, pp.2019~2022 (1988)
  44. Bantar C, "A hospitalwide intervention program to optimize the quality of antibiotic use : impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance", Clin Infect Dis, 37, pp.180~186 (2003)
  45. Davey P, "Interventions to improve antibiotic prescribing practices for hospital inpatients", Cochrane Database Syst Rev, 2, pp.CD003543~ (2017)
  46. Abbo LM, "Medical students'perceptions and knowledge about antimicrobial stewardship : how are we educating our future prescribers?", Clin Infect Dis, 57, pp.631~638 (2013)
  47. Ibrahim EH, "Experience with a clinical guideline for the treatment of ventilator-associated pneumonia", Crit Care Med, 29, pp.1109~1115 (2001)
  48. Hauck LD, "Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia", Ann Epidemiol, 14, pp.669~675 (2004)
  49. Choi Hyeah, "Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance", Infection and Chemotherapy, 54(2), pp.340~352 (2022), 대한감염학회[DOI]
  50. Gulliford MC, "Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care : REDUCE cluster randomised trial", BMJ, 364, pp.l236~ (2019)
  51. Patterson PP, "A syndrome-based approach to antimicrobial stewardship in an Arizona skilled nursing facility-moving the needle through quality improvement", Am J Infect Control, 48, pp.1537~1539 (2020)
  52. Haas MK, "Effects of a syndrome-specific antibiotic stewardship intervention for inpatient community-acquired pneumonia", Open Forum Infect Dis, 3, pp.ofw186~ (2016)
  53. Mediwala KN, "Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents", Am J Infect Control, 47, pp.1284~1289 (2019)
  54. Coates ARM, "Antibiotic combination therapy against resistant bacterial infections : synergy, rejuvenation and resistance reduction", Expert Rev Anti Infect Ther, 18, pp.5~15 (2020)
  55. Harbarth S, "Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis", Am J Med, 115, pp.529~535 (2003)
  56. Kalil AC, "Management of adults with hospital-acquired and ventilator-associated pneumonia : 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society", Clin Infect Dis, 63, pp.e61~e111 (2016)
  57. Baddour LM, "Infective endocarditis in adults : diagnosis, antimicrobial therapy, and management of complications : a scientific statement for healthcare professionals from the American Heart Association", Circulation, 132, pp.1435~1486 (2015)
  58. Tamma PD, "Combination therapy for treatment of infections with gram-negative bacteria", Clin Microbiol Rev, 25, pp.450~470 (2012)
  59. Williams P, "Pharmacokinetics", pharmacodynamics of β-lactams and therapeutic drug monitoring : from theory to practical issues in the intensive care unit, 2019, pp.40, 476~487
  60. Chastre J, "Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults : a randomized trial", JAMA, 290, pp.2588~2598 (2003)
  61. Hepburn MJ, "Comparison of short-course(5 days)and standard(10 days)treatment for uncomplicated cellulitis", Arch Intern Med, 164, pp.1669~1674 (2004)
  62. Sandberg T, "Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis : a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial", Lancet, 380, pp.484~490 (2012)
  63. Sawyer RG, "Trial of short-course antimicrobial therapy for intraabdominal infection", N Engl J Med, 372, pp.1996~2005 (2015)
  64. Chotiprasitsakul D, "Comparing the outcomes of adults with enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort", Clin Infect Dis, 66, pp.172~177 (2018)
  65. Omidvari K, "Early transition to oral antibiotic therapy for community-acquired pneumonia : duration of therapy, clinical outcomes, and cost analysis", Respir Med, 92, pp.1032~1039 (1998)
  66. Siegel RE, "A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. the optimal duration of therapy", Chest, 110, pp.965~971 (1996)
  67. Carratalà J, "Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia : a randomized controlled trial", Arch Intern Med, 172, pp.922~928 (2012)
  68. Yoon YK, "Effects of group 1 versus group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems : a before and after intervention study of carbapenem-use stewardship", PLoS One, 9, pp.e99101~ (2014)
  69. Zequinão T, "Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review", Rev Soc Bras Med Trop, 53, pp.e20200413~ (2020)
  70. McCollum M, "Cost analysis of switching from i. v. vancomycin to p. o. linezolid for the management of methicillin-resistant Staphylococcus species", Clin Ther, 25, pp.3173~3189 (2003)
  71. Huang AM, "Impact of rapid organism identification via matrix-assisted laser desorption", ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia, 2013, pp.57, 1237~1245
  72. Bauer KA, "An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus", S. aureus blood culture test in patients with S. aureus bacteremia, 2010, pp.51, 1074~1080
  73. Banerjee R, "Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing", Clin Infect Dis, 61, pp.1071~1080 (2015)
  74. 박도현, "A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients", Infection and Chemotherapy, 53(4), pp.776~785 (2021), 대한감염학회[DOI]
  75. Bonner AB, "Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department : results of a randomized, prospective, controlled trial", Pediatrics, 112, pp.363~367 (2003)
  76. Srinivas P, "Implementation of a stewardship initiative on respiratory viral PCR-based antibiotic deescalation", Pharmacotherapy, 39, pp.709~717 (2019)
  77. Peiffer-Smadja N, "Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia", Crit Care, 24, pp.366~ (2020)
  78. Bukowski PM, "Implementation of rapid diagnostic testing without active stewardship team notification for gram-positive blood cultures in a community teaching hospital", Antimicrob Agents Chemother, 62, pp.e01334~18 (2018)
  79. Avdic E, "Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with gram-positive bacteraemia", J Antimicrob Chemother, 72, pp.3191~3198 (2017)
  80. Coupat C, "Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections : a case-vignette randomised study", Eur J Clin Microbiol Infect Dis, 32, pp.627~636 (2013)
  81. Tan TY, "Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice", J Antimicrob Chemother, 51, pp.379~384 (2003)
  82. McNulty CA, "Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?", J Antimicrob Chemother, 66, pp.1396~1404 (2011)
  83. Bouadma L, "Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units(PRORATA trial) : a multicentre randomised controlled trial", Lancet, 375, pp.463~474 (2010)
  84. Prkno A, "Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis", Crit Care, 17, pp.R291~ (2013)
  85. Voiriot G, "Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia(MULTI-CAP) : a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units", BMJ Open, 11, pp.e048187~ (2021)
  86. Moradi T, "Use of procalcitonin and a respiratory polymerase chain reaction panel to reduce antibiotic use via an electronic medical record alert", Clin Infect Dis, 71, pp.1684~1689 (2020)
  87. Mullett CJ, "Development and impact of a computerized pediatric antiinfective decision support program", Pediatrics, 108, pp.E75~ (2001)
  88. Patel J, "Effective use of a clinical decision-support system to advance antimicrobial stewardship", Am J Health Syst Pharm, 69, pp.1543~1544 (2012)
  89. Bochicchio GV, "Pilot study of a web-based antibiotic decision management guide", J Am Coll Surg, 202, pp.459~467 (2006)
  90. Fralick M, "Can a smartphone app improve medical trainees' knowledge of antibiotics?", Int J Med Educ, 8, pp.416~420 (2017)
  91. Hoff BM, "Implementation of a mobile clinical decision support application to augment local antimicrobial stewardship", J Pathol Inform, 9, pp.10~ (2018)
  92. "AURA 2019: Third Australian report on antimicrobial use and resistance in human health" (2019)[URL]
  93. "Antimicrobial Use and Resistance (AUR) Module" (2021)[URL]
  94. "English surveillance programme for antimicrobial utilisation and resistance(ESPAUR)report" (2021)[URL]
  95. "Canadian Antimicrobial Resistance Surveillance System Report" (2020)[URL]
  96. Kim Bongyoung, "Development of the Korean Standardized Antimicrobial Administration Ratio as a Tool for Benchmarking Antimicrobial Use in Each Hospital", Journal of Korean Medical Science, 37(24), pp.1~11 (2022), 대한의학회[DOI]
  97. O'Leary EN, "National Healthcare Safety Network Standardized Antimicrobial Administration Ratios(SAARs) : a progress report and risk modeling update using 2017 data", Clin Infect Dis, 71, pp.e702~e709 (2020)
  99. "Core Elements of Hospital Antibiotic Stewardship Programs" (2019)[URL]
  100. Tacconelli E, "Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria : a hospital population-based study", Antimicrob Agents Chemother, 53, pp.4264~4269 (2009)
  101. Kim B, "Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: a nationwide multicenter study", Medicine (Baltimore), 97, pp.e13719~ (2018)[DOI]
  102. Kim YA, "Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates : 12-year ecological study using a nationwide surveillance and antimicrobial prescription database", PLoS One, 13, pp.e0209580~ (2018)
  103. Cisneros JM, "Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre", Clin Microbiol Infect, 20, pp.82~88 (2014)
  104. Molina J, "Long-term impact of an educational antimicrobial stewardship program on hospital-acquired candidemia and multidrug-resistant bloodstream infections : a quasi-experimental study of interrupted time-series analysis", Clin Infect Dis, 65, pp.1992~1999 (2017)
  105. Hwang H, "Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital", Sci Rep, 8, pp.14757~ (2018)
  106. Owens RC Jr, "Antimicrobial stewardship : shepherding precious resources", Am J Health Syst Pharm, 66(Suppl 4), pp.S15~S22 (2009)
  107. 김봉영, "Association between Antibiotic Consumption and Incidence of Clostridioides difficile Infection in a Hospital", Journal of Korean Medical Science, 35(47), pp.1~6 (2020), 대한의학회[DOI]
  108. Talpaert MJ, "Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection", J Antimicrob Chemother, 66, pp.2168~2174 (2011)
  109. Price J, "Impact of an intervention to control Clostridium difficile infection on hospital-and community-onset disease; an interrupted time series analysis", Clin Microbiol Infect, 16, pp.1297~1302 (2010)
  110. Kallen AJ, "Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital", Infect Control Hosp Epidemiol, 30, pp.264~272 (2009)
  111. McDonald LC, "Clinical practice guidelines for clostridium difficile infection in adults and children : 2017 update by the Infectious Diseases Society of America(IDSA)and Society for Healthcare Epidemiology of America(SHEA)", Clin Infect Dis, 66, pp.987~994 (2018)
  112. 김시호, "급성기 의료기관의 C. difficile 감염관리 전략과 전망", 의료관련감염관리, 26(2), pp.70~82 (2021), 대한의료관련감염관리학회[DOI]
  113. Honda H, "Efficacy of a postprescription review of broad-spectrum antimicrobial agents with feedback : a 4-year experience of antimicrobial stewardship at a tertiary care center", Open Forum Infect Dis, 5, pp.ofy314~ (2018)
  114. Akazawa T, "Eight-year experience of antimicrobial stewardship program and the trend of carbapenem use at a tertiary acute-care hospital in Japan-the impact of postprescription review and feedback", Open Forum Infect Dis, 6, pp.ofz389~ (2019)
  115. Al-Omari A, "The impact of antimicrobial stewardship program implementation at four tertiary private hospitals : results of a five-years pre-post analysis", Antimicrob Resist Infect Control, 9, pp.95~ (2020)
  116. 박소미, "Impact of Intervention by an Antimicrobial Stewardship Team on Conversion from Intravenous to Oral Fluoroquinolones", Infection and Chemotherapy, 49(1), pp.31~37 (2017), 대한감염학회
  117. Meeker D, "Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices : a randomized clinical trial", JAMA, 315, pp.562~570 (2016)
  118. Kiefe CI, "Improving quality improvement using achievable benchmarks for physician feedback : a randomized controlled trial", JAMA, 285, pp.2871~2879 (2001)
  119. Patel SJ, "Development of an antimicrobial stewardship intervention using a model of actionable feedback", Interdiscip Perspect Infect Dis, 2012, pp.150367~ (2012)
  120. Lee H, "Establishment of the South Korean national antimicrobial resistance surveillance system, Kor-GLASS, in 2016", Euro Surveill, 23, pp.1700734~ (2018)
  121. 김도균, "Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015", Annals of Laboratory Medicine, 37(3), pp.231~239 (2017), 대한진단검사의학회
  122. "One Health Antimicrobial resistant organism" (2022)[URL]
  123. "Duke Antimicrobial Stewardship Outreach Network homepage" (2016)[URL]
  124. Belongia EA, "Impact of statewide program to promote appropriate antimicrobial drug use", Emerg Infect Dis, 11, pp.912~920 (2005)
  125. Carling P, "Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years", Infect Control Hosp Epidemiol, 24, pp.699~706 (2003)
  126. Landgren FT, "Changing antibiotic prescribing by educational marketing", Med J Aust, 149, pp.595~599 (1988)
  127. Doron S, "Antimicrobial stewardship", Mayo Clin Proc, 86, pp.1113~1123 (2011)
  128. Weiss K, "Impact of a multipronged education strategy on antibiotic prescribing in Quebec, Canada", Clin Infect Dis, 53, pp.433~439 (2011)
  129. Regev-Yochay G, "Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention : the Israeli judicious antibiotic prescription study", Clin Infect Dis, 53, pp.33~41 (2011)
  130. Garcia Reeves AB, "Association between statewide adoption of the CDC's core elements of hospital antimicrobial stewardship programs and rates of methicillin-resistant Staphylococcus aureus bacteremia and Clostridioides difficile infection in the United States", Infect Control Hosp Epidemiol, 41, pp.430~437 (2020)
  131. Yoo M, "A Veterans'Healthcare Administration(VHA)antibiotic stewardship intervention to improve outpatient antibiotic use for acute respiratory infections : a cost-effectiveness analysis", Infect Control Hosp Epidemiol, 43, pp.1389~1395 (2022)
  132. Madaras-Kelly K, "Impact of implementation of the core elements of outpatient antibiotic stewardship within veterans health administration emergency departments and primary care clinics on antibiotic prescribing and patient outcomes", Clin Infect Dis, 73, pp.e1126~e1134 (2021)
  133. Kim B, "Current status of antimicrobial stewardship programmes in Korean hospitals : results of a 2018 nationwide survey", J Hosp Infect, 104, pp.172~180 (2020)
  134. Kim YC, "Prescriptions patterns and appropriateness of usage of antibiotics in non-teaching community hospitals in South Korea : a multicentre retrospective study", Antimicrob Resist Infect Control, 11, pp.40~ (2022)

관련 논문AI추천

Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals김신우, 박경화, 윤영경, 이미숙, 이혁민, 정혜숙, Eun Byung Wook, Hwang In Sun, Jeong Su Jin, Kim Bongyoung, Kim Hong Bin, Kim Hyung-Sook, Kim Yong Chan, Kwon Ki Tae, Moon Chisook, Park Choon-Seon, Shin Ji-Yeon대한감염학회 · Infection and Chemotherapy2022 · 제54권 제4호Developing Core Elements and Checklist Items for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals: A Modified Delphi Survey김용찬, 윤영경, 이미숙, 이혁민, 정혜숙, Eun Byung Wook, Hwang In Sun, Jeong Su Jin, Kim Bongyoung, Kim Hong Bin, Kim Hyung-Sook, Kim Shin-Woo, Kwon Ki Tae, Moon Chisook, Park Choon-Seon, Park Kyung-Hwa, Shin Ji-Yeon대한감염학회 · Infection and Chemotherapy2023 · 제55권 제1호Core Elements for Successful Implementation of Antimicrobial Stewardship Programs권기태, Hwang Soyoon대한감염학회 · Infection and Chemotherapy2021 · 제53권 제3호Implementing antimicrobial stewardship: lessons and perspectives from a university-affiliated tertiary hospital in Korea이동건, 이래석, Dukhee Nho, Hye Lim Ahn, Soo Jin Lee, Sung-Yeon Cho대한내과학회 · The Korean Journal of Internal Medicine2024 · 제39권 제3호Principles and practices of antimicrobial stewardship programs in KoreaKi Tae Kwon, Shin-Woo Kim대한내과학회 · The Korean Journal of Internal Medicine2024 · 제39권 제3호Strengthening Antimicrobial Stewardship in Korea: Strategies to Address Workforce Gaps and Expand ASP NationwideAnderson Deverick J., Ashley Elizabeth Dodds, Kim Hyung-Sook, Kim Tark, Moehring Rebekah W.대한감염학회 · Infection and Chemotherapy2025 · 제57권 제2호

이 간행물의 다른 논문 (4건)

우리나라 비대면 진료: 필수 조건에 대한 제안문석균pp. 1-3스타틴이 총 사망률에 미치는 영향배재현pp. 4-10만성 상복부 통증을 주소로 내원한 71세 남자 환자최준호pp. 40-44추정 사구체여과율의 해석김다운, 이하린pp. 45-51
원문 보기